{"id":3720,"date":"2017-03-10T12:43:36","date_gmt":"2017-03-10T12:43:36","guid":{"rendered":"http:\/\/wwwro.anm.ro\/?page_id=3720"},"modified":"2026-06-09T14:44:51","modified_gmt":"2026-06-09T11:44:51","slug":"intrebari-si-raspunsuri-referitoare-la-siguranta-medicamentelor","status":"publish","type":"page","link":"https:\/\/www.anm.ro\/en\/medicamente-de-uz-uman\/farmacovigilenta\/intrebari-si-raspunsuri-referitoare-la-siguranta-medicamentelor\/","title":{"rendered":"Questions and answers on medicinal product safety"},"content":{"rendered":"<table width=\"100%\" cellspacing=\"0\" cellpadding=\"0\" align=\"center\">\n<tbody>\n<tr>\n<td>Questions and answers on the PSUR Repository and on the manner of transmitting Periodic Safety Update Reports (PSURs).<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/PSUR%20repository%20-%20Document%20cu%20Intrebari%20si%20Raspunsuri%20pentru%20DAPP.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the recommendation of the Pharmacovigilance Risk Assessment Committee (PRAC) on Diane 35<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Document%20cu%20intrebari%20si%20raspunsuri%20referitor%20la%20recomandarile%20PRAC%20pentru%20medicamentul%20Diane%2035.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the recommendation of the Pharmacovigilance Risk Assessment Committee (PRAC) on withdrawal of oral medicinal products containing almitrine<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Q&amp;A%20referitoare%20la%20recomandarea%20PRAC%20de%20retragere%20a%20autorizatiei%20de%20punere%20pe%20piata%20pentru%20medicamentele%20care%20contin%20almitrina.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the supply shortage with Increlex (mecasermin)<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20privind%20deficitul%20de%20aprovizionare%20cu%20medicamentul%20Increlex%20%28mecasermina%29.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the supply with Caelyx (doxorubicin hydrochloride)<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20referitoare%20la%20situatia%20aprovizionarii%20cu%20medicamentul%20Caelyx%20%28clorhidrat%20de%20doxorubicina%29.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on medicinal products subject to additional monitoring<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20referitoare%20la%20medicamentele%20care%20fac%20obiectul%20monitorizarii%20suplimentare.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the recommendation of the Pharmacovigilance Risk Assessment Committee (PRAC) on restricting the use of Protelos and Osseor<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Document%20cu%20intrebari%20si%20raspunsuri%20referitor%20la%20medicamentele%20Protelos%20si%20Osseor.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the recommendation of the Pharmacovigilance Risk Assessment Committee (PRAC) for suspension of marketing authorisations for medicinal products containing tetrazepam<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20referitoare%20la%20recomandarea%20PRAC%20de%20suspendare%20a%20medicamentelor%20care%20contin%20tetrazepam.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the shortage of Vistide (cidofovir)<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20referitoare%20la%20deficitul%20de%20aprovizionare%20cu%20medicamentul%20Vistide.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers &#8211; PRAC considers that benefit-risk balance of Tredaptive, Pelzont and Trevaclyn (nicotinic acid\/laropiprant) is negative<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20referitoare%20la%20opinia%20PRAC%20privind%20raportul%20beneficiu-risc%20al%20medicamentelor%20Tredaptive,%20Pelzont%20si%20Trevaclyn.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the review the fibrin sealants Tisseel, Tissucol, Artiss and Beriplast P (and associated names), given by spray application<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20privind%20evaluarea%20medicamentelor%20hemostatice%20pe%20baza%20de%20fibrina%20Tisseel,%20Tissucol,%20Artiss,%20Beriplast%20P.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the review of medicinal products subject to trials conducted at the research base of Cetero, Texas, USA<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20referitoare%20la%20evaluarea%20medicamentelor%20care%20au%20facut%20obiectul%20unor%20studii%20desfasurate%20la%20baza%20de%20cercetare%20Cetero_Final.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the review of calcitonin-containing medicinal products<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20referitoare%20la%20reevaluarea%20medicamentelor%20care%20contin%20calcitonina%20noiembrie%202012.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the review the fibrin sealants Evicel and Quixil, given by spray application<\/p>\n<p><a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20Evicel%20si%20Quixil.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the investigation of deficiencies in the medicine-safety reporting system of Roche<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Document%20cu%20intrebari%20si%20raspunsuri%20referitor%20la%20compania%20Roche.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the review of\u00a0non-selective non-steroidal anti-inflammatory drugs (NSAIDs) and cardiovascular risk<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20referitoare%20la%20evaluarea%20AINS_final.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the review of tolperisone-containing medicines<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20referitoare%20la%20evaluarea%20medicamentelor%20care%20contin%20tolperison%202.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the review of medicinal products subject to trials conducted at the research base of Cetero, Texas, USA<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20Cetero.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the lack of sterility assurance with DepoCyte\u00a0(cytarabine)<\/p>\n<p><a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20privind%20lipsurile%20in%20asigurarea%20sterilitatii%20pentru%20medicamentul%20DepoCyte%20%28citarabina%29.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the review of Conbriza (bazedoxifene), PecFent (fentanyl) and Torisel (temsirolimus)<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20referitoare%20la%20evaluarea%20medicamentelor%20Conbriza,%20Pecfent,%20Torisel.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the review of Preflucel and associated names (influenza vaccine, purified antigen)<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20privind%20evaluarea%20vaccinului%20Preflucel%20si%20a%20denumirilor%20asociate.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the review of calcitonin-containing medicines<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20referitoare%20la%20evaluarea%20medicamentelor%20care%20contin%20calcitonina.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the review of centrally authorised medicines with ingredients manufactured at Roche Carolina Inc., Florence, USA<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20referitoare%20la%20evaluarea%20medicamentelor%20centralizate%20produse%20de%20Roche%20Carolina%20Inc.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the review of medicines containing trimetazidine<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20referitoare%20la%20evaluarea%20trimetazidinei.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the review of medicines containing trimetazidine<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20referitoare%20la%20evaluarea%20medicamentului%20Doribax%20%28doripenem%29.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the review of medicines containing tolperisone<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20referitoare%20la%20evaluarea%20medicamentelor%20care%20contin%20tolperison.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the website dedicated to the European database of adverse reaction reports<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Document%20cu%20intrebari%20si%20raspunsuri%20referitoare%20la%20website-ul%20dedicat%20bazei%20europene%20de%20rapoarte%20de%20reactii%20adverse.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the review of MabThera (rituximab)<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20referitoare%20la%20evaluarea%20medicamentului%20MabThera%20%28rituximab%29.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the review of bleeding risk with Pradaxa\u00a0(dabigatran etexilate)<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20referitoare%20la%20evaluarea%20riscului%20de%20sangerare%20asociat%20cu%20Pradaxa_final.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the review of Gilenya (fingolimod)<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20referitoare%20la%20evaluarea%20medicamentului%20Gilenya.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the review of Protelos and Osseor (strontium ranelate)<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20referitoare%20la%20evaluarea%20medicamentelor%20Protelos%20si%20Osseor%20%28ranelat%20de%20strontiu%29.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on final recommendations on Caelyx and Ceplene manufactured at Ben Venue Laboratories<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20-%20Ben%20Venue%20martie%202012.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the supply shortage of Vfend (voriconazole)<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20referitoare%20la%20deficitul%20de%20aprovizionare%20cu%20medicamentul%20Vfend%20%28voriconazol%29.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the final recommendations on 12 centrally authorised medicines manufactured at Ben Venue Laboratories<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/QA_Ben%20Venue_final.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the review of Vivaglobin (human normal immunoglobulin, solution for injection under the skin)<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Document%20cu%20intrebari%20si%20raspunsuri%20pentru%20medicamentul%20Vivaglobin.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the expression of the strength for Halaven (eribulin)<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/QA_Halaven_final.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the review aliskiren-containing medicine<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20referitoare%20la%20medicamente%20care%20contin%20aliskiren%2016.02.2012.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the review of orlistat-containing medicines<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20referitoare%20la%20evaluarea%20medicamentelor%20care%20contin%20orlistat.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the review of antifibrinolytic medicines (aprotinin, aminocaproic acid and tranexamic acid)<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/aprotininaQ_A_RO_final.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on drug interactions between Victrelis (boceprevir) and ritonavir-boosted HIV protease inhibitors<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Document%20cu%20intrebari%20si%20raspunsuri%20pentru%20medicamentul%20Victrelis%20%28boceprevir%29.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on recommendations to prevent administration errors with Velcade (bortezomib)<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20referitoare%20la%20recomandarile%20de%20prevenire%20a%20erorilor%20de%20administrare%20a%20medicamentului%20VELCADE.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the review of Gilenya (fingolimod)<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20referitoare%20la%20evaluarea%20in%20curs%20a%20medicamentului%20Gilenya.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the suspension of the marketing authorisations for oral meprobamate-containing medicines<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20referitoare%20la%20suspendarea%20autorizatiilor%20de%20punere%20pe%20piata%20a%20medicamentelor%20care%20contin%20meprobamat.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on ongoing review of aliskiren-containing medicines<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20referitoare%20la%20evaluarea%20medicamentelor%20care%20contin%20aliskiren.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on shortcomings in quality assurance at Ben Venue Laboratories<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20-%20Ben%20Venue.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the review of somatropin-containing medicines<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20referitoare%20la%20evaluarea%20medicamentelor%20care%20contin%20somatropina.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the use of Caelyx<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20privind%20utilizarea%20Caelyx.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the review of the marketing authorisations for medicines containing pholcodine<\/p>\n<p><a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20-%20suspendarea%20autorizatiei%20medicamentelor%20ce%20contin%20folcodin.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the suspension of buflomedil-containing medicines<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20privind%20suspendarea%20medicamentelor%20ce%20contin%20buflomedil.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the review of angiotensin II receptor antagonists and the risk of cancer <a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20Raspunsuri%20referitoare%20la%20Vimpat.pdf\" target=\"_blank\" rel=\"noopener noreferrer\"><br \/>\n<\/a><a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20referitoare%20la%20evaluarea%20ARBs%20si%20riscul%20de%20aparitie%20a%20cancerului_FINAL.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the shortage of Apidra (insulin glulisine) cartridges <a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20Raspunsuri%20referitoare%20la%20Vimpat.pdf\" target=\"_blank\" rel=\"noopener noreferrer\"><br \/>\n<\/a><a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20-%20Apidra.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on endotoxins in dialysis solutions produced at Baxter <a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20Raspunsuri%20referitoare%20la%20Vimpat.pdf\" target=\"_blank\" rel=\"noopener noreferrer\"><br \/>\n<\/a><a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20-%20Baxter.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the review of suppositories containing\u00a0terpenic\u00a0derivatives<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20Raspunsuri%20referitoare%20la%20Vimpat.pdf\" target=\"_blank\" rel=\"noopener noreferrer\"><br \/>\n<\/a><a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20Raspunsuri%20referitoare%20la%20supozitoarele%20cu%20terpene.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the review of Revlimid (lenalidomide)<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20Raspunsuri%20referitoare%20la%20Vimpat.pdf\" target=\"_blank\" rel=\"noopener noreferrer\"><br \/>\n<\/a><a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20Raspunsuri%20referitoare%20la%20Revlimid%20%28lenalidomida%29.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the review of Multaq (dronedarone)<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20Raspunsuri%20referitoare%20la%20Vimpat.pdf\" target=\"_blank\" rel=\"noopener noreferrer\"><br \/>\n<\/a><a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20privind%20evaluarea%20medicamentului%20Multaq%20%28dronedaron%29.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the review of Vimpat 15 mg\/ml syrup (lacosamide)<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20Raspunsuri%20referitoare%20la%20Vimpat.pdf\" target=\"_blank\" rel=\"noopener noreferrer\"><br \/>\n<\/a><a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Document%20cu%20Intrebari%20si%20Raspunsuri_Vimpat_sirop.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the supply shortage with Caelyx (doxorubicin hydrochloride)<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20Raspunsuri%20referitoare%20la%20Vimpat.pdf\" target=\"_blank\" rel=\"noopener noreferrer\"><br \/>\n<\/a><a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20Raspunsuri%20referitoare%20la%20deficitul%20de%20aprovizionare%20cu%20medicamentul%20Caelyx2.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the likely shortage of Caelyx (doxorubicin hydrochloride).<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20Raspunsuri%20referitoare%20la%20Vimpat.pdf\" target=\"_blank\" rel=\"noopener noreferrer\"><br \/>\n<\/a><a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20Raspunsuri%20referitoare%20la%20deficitul%20de%20aprovizionare%20cu%20medicamentul%20Caelyx.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the review of Pandemrix influenza vaccine\u00a0(H1N1)<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20Raspunsuri%20referitoare%20la%20Vimpat.pdf\" target=\"_blank\" rel=\"noopener noreferrer\"><br \/>\n<\/a><a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20cu%20privire%20la%20evaluarea%20vaccinului%20%20gripal%20Pandemrix.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the recall of Vimpat 15mg\/ml syrup (lacosamide)<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20Raspunsuri%20referitoare%20la%20Vimpat.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the review of pioglitazone-containing medicines (Actos, Glustin, Competact, Glubrava and Tandemact)<\/p>\n<p><a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20rspunsuri%20asupra%20evalusrii%20medicamentelor%20care%20contin%20pioglitazona%20%28Actos,%20Glustin,%20Competact,%20Glubrava%20and%20Tandemact%29.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the review of dexrazoxane-containing medicines, powder for solution for infusion, 500 mg<\/p>\n<p><a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20DEXRAZOXAN.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the review of systemic medicines containing nimesulide<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20nimesulida%20iunie%202011.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the suspension of buflomedil-containing medicines<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20Raspunsuri%20referitoare%20la%20Buflomedil.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on\u00a0the potential\u00a0off-label use of celecoxib in patients with familial adenomatous polyposis<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20Celecoxib.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the review of bisphosphonates and atypical stress fractures<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20%20bifosfonati.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the recommendation to lift the suspension of Octagam (human normal immunoglobulin 5% and 10%)<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Octagam%20%20QA_final.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the review of Tygacil (tigecycline)<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20privind%20evaluarea%20medicamentului%20Tygacil.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the supply shortage of Simponi 50 mg solution for injection in pre-filled pen<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20Raspunsuri%20referitoare%20la%20deficitul%20de%20aprovizionare%20cu%20medicamentul%20Simponi.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the review of Zerit (stavudine)<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20referitoare%20la%20evaluarea%20medicamentului%20Zerit.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on the possible risk of liver injury with Multaq (dronedarone)<br \/>\n<a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20referitoare%20la%20posibilul%20risc%20de%20afectare%20hepatica%20asociat%20cu%20utilizarea%20medicamentului%20Multaq.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<tr>\n<td>Questions and answers on endotoxins in dialysis solutions produced at Baxter manufacturing plant<\/p>\n<p><a href=\"https:\/\/www.anm.ro\/_\/INTREBARI%20SI%20RASPUNSURI\/Intrebari%20si%20raspunsuri%20privind%20prezenta%20endotoxinelor%20in%20solutiile%20pentru%20dializa%20peritoneala%20produse%20de%20compania%20Baxter.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">download document \u2026<\/a>  <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Questions and answers on the PSUR Repository and on the manner of transmitting Periodic Safety Update Reports (PSURs). download document [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":1074,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-3720","page","type-page","status-publish","hentry"],"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/www.anm.ro\/en\/wp-json\/wp\/v2\/pages\/3720","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.anm.ro\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.anm.ro\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.anm.ro\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.anm.ro\/en\/wp-json\/wp\/v2\/comments?post=3720"}],"version-history":[{"count":3,"href":"https:\/\/www.anm.ro\/en\/wp-json\/wp\/v2\/pages\/3720\/revisions"}],"predecessor-version":[{"id":12167,"href":"https:\/\/www.anm.ro\/en\/wp-json\/wp\/v2\/pages\/3720\/revisions\/12167"}],"up":[{"embeddable":true,"href":"https:\/\/www.anm.ro\/en\/wp-json\/wp\/v2\/pages\/1074"}],"wp:attachment":[{"href":"https:\/\/www.anm.ro\/en\/wp-json\/wp\/v2\/media?parent=3720"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}